Form EFFECT OKYO Pharma Ltd
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 10, 2026 9:00 A.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Total Metals Provides Exploration Drilling Update at its High Lake High-Grade Gold Project, Northwestern Ontario
- Portland General Electric Announces Third Quarter 2026 Results
- Luxxfolio Partners with Greywick Digital to Pioneer Institutional Liquidity for cLTC on the Canton Network
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share